The Discounted Cash Flow (DCF) valuation of Liminal BioSciences Inc (LMNL) is (185.00) USD. With the latest stock price at 8.50 USD, the upside of Liminal BioSciences Inc based on DCF is -2276.5%.
Based on the latest price of 8.50 USD and our DCF valuation, Liminal BioSciences Inc (LMNL) is a sell. selling LMNL stocks now will result in a potential gain of 2276.5%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.0% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (372.06) - (125.32) | (185.00) |
| Upside | -4477.1% - -1574.4% | -2276.5% |